Oramed Pharmaceuticals Inc. financial data

Symbol
ORMP on Nasdaq
Industry
Pharmaceutical Preparations
Location
1185 Avenue Of The Americas, 3 Rd Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Former names
Integrated Security Technologies, Inc. (to 4/10/2006), IGUANA VENTURES LTD (to 6/10/2004)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 396 % -88.4%
Return On Equity 12.8 %
Return On Assets 9.94 %
Operating Margin -1.01K % +30.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 40.8M shares +1.23%
Common Stock, Shares, Outstanding 40.6M shares +1.02%
Entity Public Float 131M USD -23%
Common Stock, Value, Issued 488K USD +0.83%
Weighted Average Number of Shares Outstanding, Basic 41M shares +1.83%
Weighted Average Number of Shares Outstanding, Diluted 41.6M shares +3.39%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.93M USD 0%
Research and Development Expense 5.34M USD -74.1%
Selling and Marketing Expense -663K USD -243%
General and Administrative Expense 8.19M USD -13.9%
Operating Income (Loss) -12.9M USD +56.4%
Nonoperating Income (Expense) 38.1M USD +474%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 10.8M USD
Income Tax Expense (Benefit) 1.63M USD
Net Income (Loss) Attributable to Parent 20.9M USD
Earnings Per Share, Basic 0.51 USD/shares +34.2%
Earnings Per Share, Diluted 0.51 USD/shares +34.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 18.6M USD
Marketable Securities, Current 2.35M USD +149%
Assets, Current 153M USD +1.52%
Other Long-term Investments 7.16M USD
Property, Plant and Equipment, Net 765K USD -19%
Operating Lease, Right-of-Use Asset 566K USD -32.8%
Assets 184M USD +17.9%
Employee-related Liabilities, Current 453K USD -14.4%
Liabilities, Current 3.73M USD +250%
Contract with Customer, Liability, Noncurrent 4M USD
Operating Lease, Liability, Noncurrent 236K USD -51.6%
Other Liabilities, Noncurrent 60K USD
Retained Earnings (Accumulated Deficit) -147M USD +12.4%
Stockholders' Equity Attributable to Parent 177M USD +16.8%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 176M USD +16.9%
Liabilities and Equity 184M USD +17.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.48M USD +73.4%
Net Cash Provided by (Used in) Financing Activities -19M USD -882%
Net Cash Provided by (Used in) Investing Activities 30M USD
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 40.6M shares +1.02%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9.52M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 84.8M USD +1152%
Interest Paid, Excluding Capitalized Interest, Operating Activities 571K USD
Deferred Tax Assets, Valuation Allowance 28.5M USD -13.2%
Operating Lease, Liability 486K USD -32.9%
Depreciation 56K USD +51.4%
Payments to Acquire Property, Plant, and Equipment 2K USD -99%
Lessee, Operating Lease, Liability, to be Paid 505K USD -33.5%
Operating Lease, Liability, Current 250K USD +5.93%
Lessee, Operating Lease, Liability, to be Paid, Year Two 137K USD -50.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 218K USD +58%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 19K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 18K USD -91.7%
Deferred Tax Assets, Operating Loss Carryforwards 27.8M USD +0.53%
Unrecognized Tax Benefits 11K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 10K USD 0%
Additional Paid in Capital 319M USD +5.99%
Interest Expense 592K USD